mgr Natalia Maćkowska-Maślak
Publications
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.
Provez L, Putteman T, Landfors M, Roels J, Reunes L, T’Sas S, Van Loocke W, Lintermans B, De Coninck S, Thenoz M, Sleeckx W, Maćkowska-Maślak N, Taghon T, Mansour MR, Farah N, Norga K, Vandenberghe P, Kotecha RS, Goossens S, Sofie Degerman S, RS, De Smedt R and Van Vlierberghe P
Cancers (MDPI), 2023, 15 (3): 647, 19 str, doi 10.3390/cancers15030647IF-5.2 MNiSW-140
Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T-ALL: focus on miR-363-3p and promoter methylation
Drobna-Śledzińska M, Maćkowska-Maślak N, Jaksik R, Kosmalska M, Szarzyńska B, Lejman M, Sędek Ł, Szczepański T, Taghon T, Van Vlierberghe P, Witt M, Dawidowska
M.
Genes Chromosomes Cancer, 2022 Dec, 61 (12): 720-733, doi: 10.1002/gcc.23085. Epub Jul 2IF-4,263 MNiSW-140
Small RNA-Seq Reveals Similar miRNA Transcriptome in Children and Young Adults with T-ALL and Indicates miR-143-3p as Novel Candidate Tumor Suppressor in This Leukemia
Dawidowska M, Maćkowska-Maślak N, Drobna-Śledzińska M, Kosmalska M, Jaksik R, Szymczak D, Jarmuż-Szymczak M, Sadowska-Klasa A, Wojtaszewska M, Sędek Ł, Wróbel T, Zaucha J.M, Szczepański T, Lewandowski K, Giebel S, Witt M
IF-6,208 MNiSW-140
CRISPRi for specific and miRNAs with high sequence homology.
Drobna-Śledzińska M, Maćkowska-Maślak N, Jaksik R, Dąbek P, Witt M, Dawidowska M
Scientific Reports, 2022, 12: 6237, doi: 10.1038/s41598-022-10336-3IF-4,380 MNiSW-140
DNA Methylation in T-Cell Acute Lymphoblastic Leukemia: In Search for Clinical and Biological Meaning.
Maćkowska N, Drobna-Śledzńska M, Witt M and Dawidowska M
Int J Mol Sci, Special Issue "Epigenetic Mechanisms and Human Pathology (MDPI), 2021, e1388, https://doi.org/10.3390/ijms22031388IF-4,556 MNiSW-140